Approval · Notice of Compliance 28400 · 2022
DECTOMAX: Notice of Compliance 28400
Issued June 15, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28400
- Date
- June 15, 2022
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DECTOMAX | 02231083 | Marketed |
Medicinal ingredients
- DORAMECTIN 10 MG per ML